THERAPEUTIC AGENT FOR FIBROSIS AND INHIBITOR OF NUCLEAR TRANSLOCATION OF PHOSPHORYLATED SMAD

• 收藏
• 分享

专利权人:

NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY

发明人:

Hiroyuki NAKAMURA,Toshihiko MURAYAMA

申请号：

US16661793

公开号：

US20200061038A1

申请日:

2019.10.23

申请国别(地区):

US

年份:

2020

代理人:

摘要：

A therapeutic agent for fibrosis, whose active ingredient is constituted by a glucosylceramide synthase inhibitor or lactosylceramide synthase inhibitor, or both, inhibits the nuclear translocation of phosphorylated Smad, thereby treating and preventing fibrosis.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/